Columbia Care Analyst Ratings
Columbia Care Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/18/2022 | 359.89% | Cantor Fitzgerald | $5.1 → $8.37 | Maintains | Overweight |
11/03/2021 | 185.71% | Cantor Fitzgerald | $5.5 → $5.2 | Maintains | Overweight |
08/27/2021 | 202.2% | Cantor Fitzgerald | $5.3 → $5.5 | Upgrades | Neutral → Overweight |
08/04/2021 | 191.21% | Cantor Fitzgerald | $6.75 → $5.3 | Maintains | Neutral |
07/07/2021 | 943.96% | Jefferies | → $19 | Initiates Coverage On | → Buy |
03/09/2021 | 350.55% | Cantor Fitzgerald | $8 → $8.2 | Maintains | Neutral |
02/02/2021 | 339.56% | Cantor Fitzgerald | $7.3 → $8 | Maintains | Neutral |
01/08/2021 | 301.1% | Cantor Fitzgerald | → $7.3 | Initiates Coverage On | → Neutral |
08/25/2020 | — | Needham | Initiates Coverage On | → Hold |
日期 | 上行/下行 | 分析師公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
08/18/2022 | 359.89% | 坎託·菲茨傑拉德 | 5.1 美元 → 8.37 美元 | 維護 | 超重 |
11/03/2021 | 185.71% | 坎託·菲茨傑拉德 | 5.5 美元 → 5.2 美元 | 維護 | 超重 |
08/27/2021 | 202.2% | 坎託·菲茨傑拉德 | 5.3 美元 → 5.5 美元 | 升級 | 中立 → 超重 |
08/04/2021 | 191.21% | 坎託·菲茨傑拉德 | 6.75 美元 → 5.3 美元 | 維護 | 中立 |
2021 年 7 月 7 日 | 943.96% | 傑富瑞集團 | → 19 美元 | 啓動覆蓋範圍開啓 | → 購買 |
2021 年 9 月 3 日 | 350.55% | 坎託·菲茨傑拉德 | 8 美元 → 8.2 美元 | 維護 | 中立 |
02/02/2021 | 339.56% | 坎託·菲茨傑拉德 | 7.3 美元 → 8 美元 | 維護 | 中立 |
01/08/2021 | 301.1% | 坎託·菲茨傑拉德 | → 7.3 美元 | 啓動覆蓋範圍開啓 | → 中立 |
08/25/2020 | — | 尼德姆 | 啓動覆蓋範圍開啓 | → 按住 |
Columbia Care Questions & Answers
哥倫比亞醫療常見問題與解答
The latest price target for Columbia Care (OTCQX: CCHWF) was reported by Cantor Fitzgerald on August 18, 2022. The analyst firm set a price target for $8.37 expecting CCHWF to rise to within 12 months (a possible 359.89% upside). 3 analyst firms have reported ratings in the last year.
坎託·菲茨傑拉德於2022年8月18日公佈了哥倫比亞醫療(OTCQX:CCHWF)的最新目標股價。該分析公司將目標股價定爲8.37美元,預計CCHWF將在12個月內升至12個月內(可能上漲359.89%)。去年有3家分析公司公佈了評級。
The latest analyst rating for Columbia Care (OTCQX: CCHWF) was provided by Cantor Fitzgerald, and Columbia Care maintained their overweight rating.
坎託·菲茨傑拉德對哥倫比亞醫療(OTCQX:CCHWF)的最新分析師評級由坎託·菲茨傑拉德提供,哥倫比亞醫療維持增持評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Columbia Care, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Columbia Care was filed on August 18, 2022 so you should expect the next rating to be made available sometime around August 18, 2023.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與哥倫比亞醫療公司的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級,因此每家公司每年應該獲得4次評級。哥倫比亞醫療的最新評級是在2022年8月18日公佈的,因此您應該預計下一個評級將在2023年8月18日左右公佈。
While ratings are subjective and will change, the latest Columbia Care (CCHWF) rating was a maintained with a price target of $5.10 to $8.37. The current price Columbia Care (CCHWF) is trading at is $1.82, which is out of the analyst's predicted range.
儘管評級是主觀的,並且會發生變化,但最新的哥倫比亞醫療(CCHWF)評級維持不變,目標股價爲5.10美元至8.37美元。哥倫比亞醫療(CCHWF)目前的交易價格爲1.82美元,超出了分析師的預期區間。